| SARS-CoV-2 and stroke characteristics: a report from the multinational COVID-19 stroke study group S Shahjouei, G Tsivgoulis, G Farahmand, E Koza, A Mowla, A Vafaei Sadr, ... Stroke 52 (5), e117-e130, 2021 | 86 | 2021 |
| Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone/metoclopramide on alleviating acute migraine headache A Shahrami, F Assarzadegan, HR Hatamabadi, M Asgarzadeh, ... The Journal of emergency medicine 48 (1), 69-76, 2015 | 69 | 2015 |
| Serum concentration of magnesium as an independent risk factor in migraine attacks: a matched case–control study and review of the literature F Assarzadegan, S Asgarzadeh, HR Hatamabadi, A Shahrami, ... International Clinical Psychopharmacology 31 (5), 287-292, 2016 | 48 | 2016 |
| Central nervous system manifestations in COVID‐19 patients: a systematic review and meta‐analysis S Nazari, A Azari Jafari, S Mirmoeeni, S Sadeghian, ME Heidari, ... Brain and Behavior 11 (5), e02025, 2021 | 45 | 2021 |
| Risk factors for increased multiple sclerosis susceptibility in the Iranian population B Mansouri, S Asadollahi, K Heidari, M Fakhri, F Assarzadegan, M Nazari, ... Journal of Clinical Neuroscience 21 (12), 2207-2211, 2014 | 45 | 2014 |
| The efficacy of gabapentin in patients with central post-stroke pain O Hesami, N Beladimoghadam, F Assarzadegan, B Mansouri, ... Iranian Journal of Pharmaceutical Research: IJPR 14 (Suppl), 95, 2015 | 43 | 2015 |
| Secondary headaches attributed to arterial hypertension F Assarzadegan, M Asadollahi, O Hesami, O Aryani, B Mansouri Iranian Journal of Neurology 12 (3), 106, 2013 | 36 | 2013 |
| Neurological features and outcome in COVID-19: dementia can predict severe disease M Ghaffari, H Ansari, N Beladimoghadam, SH Aghamiri, M Haghighi, ... Journal of NeuroVirology 27, 86-93, 2021 | 33 | 2021 |
| Protective properties of the aqueous extract of saffron (Crocus sativus L.) in ischemic stroke, randomized clinical trial M Asadollahi, P Nikdokht, B Hatef, SS Sadr, H Sahraei, F Assarzadegan, ... Journal of ethnopharmacology 238, 111833, 2019 | 33 | 2019 |
| Relationship between intracerebral hemorrhage and diabetes mellitus: a case-control study O Hesami, HD Kasmaei, F Matini, F Assarzadegan, B Mansouri, ... Journal of clinical and diagnostic research: JCDR 9 (4), OC08, 2015 | 32 | 2015 |
| Relation of stroke risk factors with specific stroke subtypes and territories F Assarzadegan, H Tabesh, A Shoghli, MG Yazdi, H Tabesh, ... Iranian Journal of Public Health 44 (10), 1387, 2015 | 26 | 2015 |
| Coronavirus disease 2019 and stroke in Iran: a case series and effects on stroke admissions M Mehrpour, A Shuaib, M Farahani, HR Hatamabadi, Z Fatehi, M Ghaffari, ... International Journal of Stroke 16 (9), 1047-1052, 2021 | 24 | 2021 |
| Mortality and functional disability after spontaneous intracranial hemorrhage: the predictive impact of overall admission factors B Mansouri, K Heidari, S Asadollahi, M Nazari, F Assarzadegan, A Amini Neurological Sciences 34, 1933-1939, 2013 | 24 | 2013 |
| COVID-19 respiratory illness and subsequent cerebrovascular events, the initial iranian experience B Sabayan, M Moghadami, F Assarzadegan, SHA Komachali, ... Journal of Stroke and Cerebrovascular Diseases 30 (1), 105454, 2021 | 20 | 2021 |
| Comparison of pregabalin and sodium valproate in migraine prophylaxis: a randomized double-blinded study O Hesami, MR Shams, L Ayazkhoo, F Assarzadegan, BS Lima, ... Iranian journal of pharmaceutical research: IJPR 17 (2), 783, 2018 | 20 | 2018 |
| Acute management of stroke in Iran: Obstacles and solutions S Shahjouei, R Bavarsad-Shahripour, F Assarzadegan, R Rikhtegar, ... Iranian journal of neurology 16 (2), 62, 2017 | 17 | 2017 |
| Tolerability and efficacy of memantine as add on therapy in patients with migraine F Assarzadegan, M Sistanizad Iranian journal of pharmaceutical research: IJPR 16 (2), 791, 2017 | 17 | 2017 |
| Evaluation of ocular side effects in the patients on topiramate therapy for control of migrainous headache O Hesami, SS Hosseini, N Kazemi, SM Hosseini-Zijoud, NB Moghaddam, ... Journal of clinical and diagnostic research: JCDR 10 (3), NC01, 2016 | 17 | 2016 |
| Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran H Pakdaman, A Amini Harandi, K Gharagozli, M Abbasi, A Tabassi, ... International Journal of Neuroscience 127 (6), 501-507, 2017 | 16 | 2017 |
| Efficacy and safety of MLC601 in the treatment of mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled study H Pakdaman, A Amini Harandi, M Abbasi, H Delavar Kasmaei, F Ashrafi, ... Dementia and Geriatric Cognitive Disorders Extra 7 (1), 136-142, 2017 | 12 | 2017 |
